▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁app 8.234375
▁ar 10.0234375
ent 7.234375
▁link 9.5546875
▁between 4.1640625
▁pain 7.3984375
▁and 0.86572265625
▁dem 7.86328125
oral 3.470703125
ization 0.5458984375
. 1.6044921875
▁Chron 6.0
ic 0.0241546630859375
▁pain 0.58447265625
▁is 1.3408203125
▁always 6.1796875
▁accompanied 3.818359375
▁by 0.06689453125
▁negative 4.62109375
▁emot 1.52734375
ional 1.3955078125
▁experiences 2.857421875
▁and 2.28125
▁blocks 11.2578125
▁a 4.08984375
▁person 1.44140625
’ 24.8125
s 2.408203125
▁ability 2.501953125
▁to 0.06927490234375
▁receive 6.125
▁joy 5.03515625
▁and 1.359375
▁satisfaction 3.189453125
▁from 1.115234375
▁life 1.107421875
. 0.3251953125
▁The 2.0234375
▁research 3.84375
▁investig 5.28125
ates 0.60595703125
▁the 0.501953125
▁development 5.66015625
▁of 0.1884765625
▁de 3.8203125
pression 0.239013671875
▁and 1.220703125
▁anx 2.296875
iety 0.00406646728515625
▁among 2.421875
▁patients 2.33203125
▁receiving 4.67578125
▁ph 6.1484375
arma 2.064453125
ce 0.01161956787109375
ut 0.0004773139953613281
ical 0.009979248046875
▁op 4.66796875
io 0.13671875
ids 0.69384765625
▁and 2.390625
▁medical 6.078125
▁mar 1.2939453125
iju 0.03350830078125
ana 0.0003292560577392578
▁( 4.70703125
MM 0.6416015625
) 3.138671875
▁as 2.982421875
▁severe 9.9140625
▁pain 1.5888671875
kill 3.66015625
ers 0.0026226043701171875
. 0.53857421875
▁It 3.439453125
▁comp 5.65234375
ares 0.06280517578125
▁the 0.68603515625
▁effic 6.4296875
acy 0.00896453857421875
▁of 0.256591796875
▁pres 5.16015625
cri 1.837890625
ptions 0.73486328125
▁and 2.30078125
▁exam 6.09375
ines 0.01446533203125
▁the 0.474609375
▁possibility 4.140625
▁of 0.1064453125
▁post 6.9609375
- 0.705078125
tre 2.5
at 0.0164794921875
ment 0.0098724365234375
▁de 1.9013671875
pression 0.0989990234375
. 1.720703125
<0x0A> 2.400390625
There 4.74609375
▁is 1.119140625
▁currently 4.67578125
▁a 1.3330078125
▁severe 5.03515625
▁lack 3.236328125
▁of 0.027069091796875
▁information 2.134765625
▁about 1.384765625
▁the 0.494140625
▁effects 2.796875
▁of 0.0751953125
▁op 1.8857421875
i 4.04296875
ates 0.128173828125
. 3.779296875
▁They 4.90625
▁manage 8.7890625
▁pain 3.623046875
▁successfully 5.83203125
, 1.0556640625
▁but 0.330078125
▁the 2.64453125
▁past 9.453125
▁few 2.630859375
▁dec 0.85888671875
ades 9.846687316894531e-05
▁indicated 9.5390625
▁the 2.0703125
▁growing 4.69140625
▁concern 3.46484375
▁regarding 2.791015625
▁op 3.4453125
iate 0.6806640625
▁ab 1.49609375
use 0.00803375244140625
▁in 3.431640625
▁forms 10.578125
▁of 0.390625
▁over 3.23046875
d 0.362548828125
ose 0.1837158203125
▁and 0.7119140625
▁add 1.099609375
iction 0.0267181396484375
. 0.2159423828125
▁A 4.0
▁more 5.74609375
▁manage 8.8359375
able 0.00531005859375
▁and 2.26171875
▁sa 2.29296875
fer 0.00010704994201660156
▁alternative 1.744140625
▁might 6.44140625
▁be 0.18115234375
▁medical 2.6328125
▁mar 0.185546875
iju 0.004245758056640625
ana 0.0007328987121582031
. 1.556640625
▁However 2.890625
, 0.00804901123046875
▁the 1.6220703125
▁legal 4.390625
▁status 1.171875
▁and 2.75390625
▁novel 9.140625
ty 0.6416015625
▁of 0.221435546875
▁this 1.6982421875
▁drug 2.083984375
▁do 5.05859375
▁not 0.0728759765625
▁allow 1.025390625
▁finding 8.78125
▁a 2.345703125
▁large 4.23046875
▁number 1.4189453125
▁of 0.005489349365234375
▁studies 1.2861328125
▁on 1.5283203125
▁its 1.015625
▁effect 2.005859375
iveness 0.374755859375
. 1.0146484375
▁Specifically 8.140625
, 0.11431884765625
▁it 2.71875
▁concerns 4.6875
▁the 0.640625
▁emot 7.1171875
ional 0.017852783203125
▁condition 5.42578125
▁of 0.374267578125
▁patients 0.728515625
▁experien 6.37890625
cing 5.5670738220214844e-05
▁chron 1.107421875
ic 0.0019664764404296875
▁pain 0.09490966796875
. 0.6533203125
▁This 3.154296875
▁research 3.0078125
▁paper 6.1640625
▁a 2.169921875
ims 0.0007228851318359375
▁to 0.08941650390625
▁analyze 3.0234375
▁levels 9.515625
▁of 0.03680419921875
▁de 0.5732421875
pression 0.038787841796875
▁and 0.25341796875
▁anx 0.0455322265625
iety 0.0012807846069335938
▁among 0.79150390625
▁people 3.240234375
▁receiving 0.9609375
▁ther 7.91796875
apy 0.315185546875
▁by 5.109375
▁comparing 7.84375
▁the 1.0126953125
▁effects 2.12890625
▁of 0.03125
▁ph 2.595703125
arma 0.05859375
ce 0.0015287399291992188
ut 7.736682891845703e-05
ical 0.003925323486328125
▁op 0.312744140625
io 0.1495361328125
ids 0.058685302734375
▁and 0.278076171875
▁MM 1.2919921875
. 1.01953125
<0x0A> 0.98291015625
The 1.37109375
▁study 1.98828125
▁was 2.12109375
▁conducted 0.73876953125
▁in 1.580078125
▁the 1.4638671875
▁form 2.1171875
▁of 0.01142120361328125
▁collection 10.2421875
▁and 1.7041015625
▁analysis 0.67236328125
▁of 0.050628662109375
▁statistical 4.25390625
▁data 0.119140625
. 0.93603515625
▁Part 4.93359375
icip 0.0628662109375
ants 0.043853759765625
▁were 0.7177734375
▁rec 3.279296875
ru 0.0011930465698242188
ited 4.839897155761719e-05
▁for 4.0234375
▁six 7.359375
▁months 0.509765625
▁at 3.75
▁two 2.580078125
▁major 5.4765625
▁pain 2.916015625
▁relief 5.30859375
▁cent 1.517578125
ers 0.0711669921875
▁in 0.7119140625
▁Israel 4.33203125
. 0.422119140625
▁The 1.197265625
▁research 2.189453125
ers 1.544921875
▁used 2.666015625
▁The 7.95703125
▁De 4.08203125
pression 0.01242828369140625
▁Module 10.015625
▁of 0.974609375
▁the 0.330078125
▁Pat 2.2265625
ient 0.00766754150390625
▁Health 0.08526611328125
▁Question 0.014892578125
naire 0.0191192626953125
▁and 3.392578125
▁the 0.6796875
▁General 1.736328125
ized 0.6826171875
▁An 0.016937255859375
x 0.00015091896057128906
iety 0.003070831298828125
▁Dis 0.49365234375
order 0.03338623046875
▁Sc 1.2177734375
ale 0.0718994140625
▁to 1.71875
▁interview 7.0703125
▁participants 2.001953125
, 3.7109375
▁evaluate 5.6015625
▁their 0.74755859375
▁answers 6.52734375
, 0.85107421875
▁and 0.14453125
▁conduct 4.484375
▁the 2.33203125
▁study 2.23046875
. 0.2286376953125
▁To 5.1015625
▁specifically 9.859375
▁evaluate 2.5625
▁and 4.3671875
▁compare 0.95361328125
▁the 0.337646484375
▁prob 11.109375
abilities 0.1668701171875
▁of 0.1328125
▁de 0.80908203125
pression 0.038818359375
▁or 4.59375
▁anx 0.03839111328125
iety 0.0003650188446044922
▁among 1.720703125
▁the 2.2890625
▁diverse 8.9296875
▁groups 1.5732421875
, 1.404296875
▁the 1.0029296875
▁study 2.662109375
▁used 1.6220703125
▁multiple 4.74609375
▁log 2.802734375
istic 0.0369873046875
▁regression 0.10235595703125
▁analysis 0.6767578125
▁and 2.537109375
▁chose 8.9375
▁medical 7.4453125
▁mar 0.27490234375
iju 0.0019464492797851562
ana 0.00027561187744140625
▁as 0.82568359375
▁the 1.1435546875
▁control 2.658203125
▁group 0.55517578125
. 0.295654296875
<0x0A> 0.77734375
This 3.4609375
▁type 6.08984375
▁of 0.00920867919921875
▁study 1.67578125
▁is 1.28515625
▁the 3.435546875
▁most 1.88671875
▁reve 9.25
aling 0.0007166862487792969
▁and 1.060546875
▁inclus 6.42578125
ive 0.0026569366455078125
, 2.29296875
▁as 1.9033203125
▁it 0.35693359375
▁contains 4.8828125
▁direct 6.53125
▁responses 4.953125
▁from 0.83740234375
▁a 3.8984375
▁large 0.94091796875
▁number 0.45849609375
▁of 0.004116058349609375
▁participants 1.4072265625
. 0.64990234375
▁All 4.6484375
▁tools 9.0390625
▁in 4.5625
▁the 0.66259765625
▁form 3.46875
▁of 0.045806884765625
▁question 1.8017578125
na 0.03643798828125
ires 9.5367431640625e-05
▁and 2.12890625
▁scales 2.98046875
▁have 3.65625
▁already 4.5234375
▁been 0.1910400390625
▁used 1.93359375
▁and 2.10546875
▁proved 4.19140625
▁their 1.7919921875
▁effic 4.0
acy 7.545948028564453e-05
▁for 3.587890625
▁collect 4.67578125
ing 0.018310546875
▁analyt 8.2578125
ical 0.23974609375
▁data 0.27978515625
. 0.435302734375
▁It 3.55078125
▁helps 4.69921875
▁to 0.95849609375
▁system 7.32421875
at 1.3251953125
ize 0.00574493408203125
▁and 1.5869140625
▁class 4.08984375
ify 0.00223541259765625
▁distinct 9.2734375
▁kinds 6.29296875
▁of 0.0253143310546875
▁information 3.4609375
▁for 3.89453125
▁subsequent 4.12109375
▁un 8.015625
comp 5.42578125
licated 0.0582275390625
▁services 11.75
. 0.65869140625
▁Thus 4.35546875
, 0.0228271484375
▁research 4.4609375
ers 0.5078125
▁can 1.3857421875
▁compare 3.939453125
▁the 0.94921875
▁effects 2.990234375
▁of 0.10662841796875
▁medic 4.41796875
ations 0.884765625
▁on 1.81640625
▁patients 2.1171875
▁of 4.44140625
▁diverse 4.1171875
▁age 2.66796875
▁groups 0.6962890625
, 0.90234375
▁background 5.02734375
s 0.2198486328125
, 0.06695556640625
▁physical 5.39453125
▁conditions 1.4296875
, 0.08544921875
▁emot 5.5
ional 0.06549072265625
▁states 1.416015625
, 0.10479736328125
▁and 0.446533203125
▁so 3.181640625
▁on 0.328125
. 0.090087890625
<0x0A> 0.6416015625
The 1.1015625
▁analysis 4.4609375
▁of 0.591796875
▁any 8.8203125
▁human 6.11328125
▁reaction 4.859375
▁has 4.57421875
▁a 1.744140625
▁high 4.48046875
▁potential 3.462890625
▁of 1.6533203125
▁subject 6.05859375
iveness 3.900390625
▁and 1.3408203125
▁bias 2.263671875
, 1.880859375
▁especially 2.416015625
▁regarding 4.3828125
▁people 4.45703125
▁in 3.947265625
▁severe 4.3203125
▁pain 0.2880859375
▁and 2.634765625
▁un 5.39453125
stable 1.8369140625
▁emot 0.822265625
ional 0.1676025390625
▁condition 2.5625
. 0.07476806640625
▁Perhaps 8.9296875
▁some 5.05078125
▁patients 2.36328125
▁tend 5.421875
▁to 0.020721435546875
▁ex 2.552734375
agger 0.0014181137084960938
ate 0.00562286376953125
▁their 0.751953125
▁de 5.15625
press 1.3876953125
ive 0.263671875
▁state 3.138671875
▁or 1.8896484375
▁vice 7.34765625
▁vers 0.012542724609375
a 4.3392181396484375e-05
, 0.9833984375
▁de 7.484375
- 4.9375
emph 0.9423828125
as 0.005390167236328125
ize 0.12200927734375
▁serious 6.62890625
▁difficulties 5.89453125
. 0.890625
▁Because 6.18359375
▁the 2.294921875
▁survey 6.171875
▁responses 6.640625
▁were 1.62890625
▁thoroughly 7.84375
▁anonymous 5.30078125
, 0.458740234375
▁the 1.44921875
▁research 1.5341796875
ers 0.28125
▁were 1.431640625
▁unable 2.470703125
▁to 0.0033702850341796875
▁carefully 8.8046875
▁analyze 1.5732421875
▁each 3.953125
▁patient 2.515625
’ 27.15625
s 0.646484375
▁reaction 3.728515625
▁and 2.384765625
▁compare 3.5
▁it 0.923828125
▁to 1.2490234375
▁the 0.7568359375
▁actual 5.86328125
▁states 7.203125
▁of 0.71923828125
▁condition 7.21484375
. 0.3828125
▁More 6.8984375
▁accurate 3.751953125
▁answers 4.62890625
▁could 2.51171875
▁be 0.91259765625
▁obtained 1.021484375
▁by 1.3564453125
▁professional 7.42578125
▁psych 2.162109375
olog 0.30517578125
ists 0.0010223388671875
▁via 7.89453125
▁personal 3.966796875
▁communication 4.66015625
▁and 1.8310546875
▁behavior 7.12109375
al 0.35205078125
▁analysis 2.25390625
. 0.227294921875
▁However 2.703125
, 0.0027523040771484375
▁this 1.9423828125
▁method 2.83203125
▁of 2.279296875
▁research 2.146484375
▁is 0.95263671875
▁way 7.8203125
▁more 1.7001953125
▁resource 6.51171875
- 0.467529296875
int 0.54833984375
ensive 0.0081787109375
▁and 0.62646484375
▁energy 8.6640625
- 0.1190185546875
consum 0.313720703125
ing 0.0016689300537109375
. 0.5966796875
<0x0A> 0.65234375
Part 5.60546875
icip 0.0872802734375
ants 0.11077880859375
▁were 1.0234375
▁rec 1.5751953125
ru 0.0011444091796875
ited 8.308887481689453e-05
▁for 1.130859375
▁six 1.1474609375
▁months 0.0210723876953125
▁at 0.47412109375
▁two 0.11077880859375
▁major 0.373046875
▁pain 0.03424072265625
▁relief 0.0296478271484375
▁cent 0.0300750732421875
ers 0.004711151123046875
▁in 0.06329345703125
▁Israel 0.033050537109375
. 0.1451416015625
▁All 3.4921875
▁patients 1.533203125
▁experienced 5.5859375
▁chron 1.9677734375
ic 0.002323150634765625
▁pain 0.09259033203125
▁for 3.578125
▁at 0.716796875
▁least 0.00098419189453125
▁ 1.1015625
3 1.4482421875
▁months 0.2271728515625
. 1.0693359375
▁The 1.4619140625
▁study 1.921875
▁included 2.16015625
▁ 1.111328125
8 2.87109375
9 2.755859375
0 3.5546875
▁participants 1.5029296875
, 1.224609375
▁of 1.7822265625
▁which 0.40576171875
▁ 0.1494140625
4 1.603515625
7 2.4609375
4 2.75
▁( 2.224609375
5 0.09100341796875
9 11.1484375
%) 1.0185546875
▁were 0.47802734375
▁treated 4.6796875
▁sole 6.7734375
ly 0.00012600421905517578
▁with 0.457763671875
▁op 0.78857421875
io 0.403564453125
ids 0.1864013671875
, 1.1513671875
▁ 0.595703125
3 1.076171875
2 2.091796875
9 2.541015625
▁( 0.043731689453125
4 1.1689453125
1 1.248046875
%) 0.1304931640625
▁were 1.3203125
▁treated 0.5537109375
▁with 0.182373046875
▁MM 0.67529296875
, 0.272216796875
▁and 0.154052734375
▁ 0.1419677734375
7 3.205078125
7 2.412109375
▁( 0.17138671875
8 3.841796875
. 1.150390625
6 3.05859375
%) 0.05499267578125
▁acquired 9.609375
▁both 1.138671875
▁( 7.07421875
Fe 10.21875
ing 2.765625
old 0.018829345703125
▁et 1.3525390625
▁al 0.01800537109375
., 0.33056640625
▁ 0.01012420654296875
2 0.1373291015625
0 0.0003216266632080078
1 0.367919921875
7 2.041015625
). 0.12060546875
▁The 1.33984375
▁remaining 6.98046875
▁ten 8.1015625
▁participants 1.3896484375
▁who 5.6171875
▁did 1.451171875
▁not 0.00691986083984375
▁receive 1.83984375
▁ph 3.08984375
arma 0.07525634765625
ce 0.0015649795532226562
ut 2.002716064453125e-05
ical 0.00348663330078125
▁op 1.03125
io 0.07958984375
ids 0.0224761962890625
▁and 1.6357421875
▁medical 2.2578125
▁mar 0.04583740234375
iju 0.004657745361328125
ana 0.00010263919830322266
▁were 1.3115234375
▁with 6.09375
dra 0.1409912109375
wn 0.00012159347534179688
▁from 0.259521484375
▁the 0.10858154296875
▁analysis 4.60546875
▁in 4.79296875
▁the 1.1689453125
▁research 4.28125
. 0.73974609375
▁Therefore 4.82421875
, 0.00792694091796875
▁it 3.759765625
▁is 0.91259765625
▁not 2.712890625
▁possible 0.65380859375
▁to 0.019866943359375
▁compreh 6.53125
ens 0.048675537109375
ively 0.0090484619140625
▁compare 1.87890625
▁patients 4.80078125
▁taking 4.11328125
▁medic 3.826171875
ations 0.51953125
▁with 0.95361328125
▁those 1.1904296875
▁who 1.1376953125
▁do 1.71875
▁not 0.00839996337890625
. 0.7880859375
<0x0A> 0.658203125
The 1.1015625
▁study 1.6708984375
▁conducted 4.6640625
▁a 2.044921875
▁correlation 5.9765625
▁type 7.4140625
▁of 0.475341796875
▁research 2.029296875
▁with 2.841796875
▁variable 7.98828125
▁measures 4.6171875
. 1.275390625
▁It 2.1015625
▁evaluated 4.359375
▁the 0.58544921875
▁inter 6.15625
dep 3.58203125
end 0.00054168701171875
ence 0.01029205322265625
▁of 0.529296875
▁various 3.92578125
▁factors 1.626953125
▁that 2.80859375
▁affected 4.0859375
▁the 0.5703125
▁physical 6.94921875
▁and 0.94189453125
▁emot 0.467041015625
ional 0.00036525726318359375
▁condition 1.0185546875
▁of 0.11163330078125
▁patients 0.60791015625
▁experien 4.25390625
cing 2.002716064453125e-05
▁ 9.078125
▁chron 7.75
ic 0.0004718303680419922
▁pain 0.03485107421875
. 0.2376708984375
▁For 3.8984375
▁example 1.1201171875
, 0.0206451416015625
▁the 1.2041015625
▁survey 5.234375
▁showed 3.478515625
▁that 0.403564453125
▁the 1.71484375
▁ratio 6.9921875
▁of 0.1300048828125
▁female 4.57421875
▁patients 0.76806640625
▁was 1.8359375
▁remark 9.609375
ably 0.0005817413330078125
▁higher 0.5302734375
▁in 2.669921875
▁the 0.9814453125
▁op 4.546875
i 4.11328125
ates 0.0814208984375
▁group 0.26904296875
▁compared 2.740234375
▁to 0.123291015625
▁the 0.552734375
▁MM 0.47314453125
▁group 0.30078125
. 0.490234375
▁In 2.982421875
▁turn 4.01953125
, 0.0031871795654296875
▁people 6.015625
▁on 5.484375
▁op 1.4345703125
i 0.4580078125
ates 0.0034885406494140625
▁were 1.0703125
▁more 0.9892578125
▁likely 0.378173828125
▁to 0.06304931640625
▁report 3.11328125
▁major 6.015625
▁de 0.3798828125
press 1.2392578125
ive 0.004070281982421875
▁dis 0.497802734375
orders 1.3955078125
. 1.7880859375
<0x0A> 2.380859375
The 1.1181640625
▁question 5.69140625
na 1.47265625
ires 8.344650268554688e-05
▁used 2.025390625
▁different 8.078125
▁variable 8.6953125
▁measures 0.7939453125
▁to 1.3564453125
▁collect 2.34765625
▁information 1.96484375
. 1.65625
▁For 1.96484375
▁example 0.1942138671875
, 0.0084228515625
▁it 4.0
▁included 2.46875
▁compreh 8.703125
ensive 0.027435302734375
▁so 6.87890625
cio 0.0210723876953125
- 0.396484375
dem 0.081298828125
ographic 0.040374755859375
▁data 0.99658203125
: 4.84375
▁gender 1.587890625
, 0.09368896484375
▁age 0.204833984375
, 0.09075927734375
▁country 4.34765625
, 1.4609375
▁type 4.359375
▁of 0.056915283203125
▁residence 3.865234375
▁( 3.55078125
urban 2.0546875
/ 2.94140625
r 0.06317138671875
ural 0.000514984130859375
), 0.2423095703125
▁years 5.953125
▁of 0.1671142578125
▁education 0.671875
, 0.1441650390625
▁and 1.8544921875
▁employ 3.6796875
ment 0.004138946533203125
▁status 0.455078125
. 0.177490234375
▁Pat 4.07421875
ients 0.11578369140625
▁were 1.158203125
▁also 0.89013671875
▁asked 0.6103515625
▁about 1.125
▁their 0.62890625
▁medical 2.720703125
▁history 0.40966796875
over 18.1875
▁the 0.436767578125
▁years 3.248046875
▁and 1.9150390625
▁the 1.798828125
▁current 3.21875
▁presence 5.8828125
▁of 0.0587158203125
▁any 2.66796875
▁severe 4.51953125
▁dise 1.5
ases 0.00020122528076171875
▁such 4.09375
▁as 0.00569915771484375
▁heart 2.400390625
▁failure 2.017578125
, 0.177001953125
▁di 1.861328125
ab 0.0019054412841796875
etes 0.004741668701171875
, 0.1357421875
▁ar 3.73828125
th 0.2020263671875
rit 0.03594970703125
is 0.01096343994140625
, 0.05426025390625
▁and 1.5947265625
▁so 0.724609375
▁on 0.031280517578125
. 0.054656982421875
▁The 1.89453125
▁third 7.1875
▁measure 3.900390625
▁of 2.04296875
▁the 1.0029296875
▁question 2.99609375
naire 0.1595458984375
▁was 0.96484375
▁indicated 9.78125
▁by 0.65771484375
▁information 6.5625
▁on 1.5947265625
▁any 5.30078125
▁twelve 13.6640625
- 1.2333984375
month 0.3701171875
▁and 5.7734375
▁lifetime 3.212890625
▁drug 4.69140625
▁and 3.4453125
▁alco 0.07757568359375
hol 0.00010645389556884766
▁consumption 2.669921875
. 0.468994140625
▁In 3.494140625
▁addition 0.78857421875
, 0.1199951171875
▁the 1.1455078125
▁record 7.8359375
▁included 1.7470703125
▁a 2.509765625
▁pain 6.36328125
▁measurement 4.33203125
▁scale 1.0712890625
▁from 3.662109375
▁ 0.446044921875
0 0.474365234375
▁to 0.427734375
▁ 0.00672149658203125
1 0.082763671875
0 0.07080078125
▁to 4.5859375
▁evaluate 1.5498046875
▁dis 5.890625
com 0.2076416015625
fort 0.001331329345703125
▁feelings 7.359375
▁during 3.30859375
▁the 0.89501953125
▁last 1.41015625
▁month 1.6201171875
. 0.285400390625
<0x0A> 1.158203125
Am 6.953125
ong 0.0108489990234375
▁all 2.375
▁participants 1.9482421875
▁in 3.541015625
▁the 0.17724609375
▁study 0.37109375
, 0.060394287109375
▁ 0.66064453125
4 1.81640625
2 2.72265625
. 1.8251953125
2 2.296875
% 0.1405029296875
▁suffered 4.9140625
▁from 0.1422119140625
▁de 1.7900390625
pression 0.1512451171875
, 1.06640625
▁and 1.76953125
▁ 0.150634765625
3 1.7119140625
7 2.236328125
% 2.728515625
▁experienced 2.318359375
▁excess 7.8125
ive 0.0867919921875
▁anx 0.25732421875
iety 0.0017137527465820312
. 0.351806640625
▁The 1.416015625
▁pl 11.15625
ur 1.0498046875
ality 0.00021374225616455078
▁of 0.1922607421875
▁de 3.578125
press 1.296875
ive 0.0248260498046875
▁dis 1.8525390625
orders 0.06475830078125
▁among 3.794921875
▁patients 1.18359375
▁in 3.650390625
▁the 0.3759765625
▁op 1.4619140625
i 1.0146484375
ates 0.00496673583984375
, 7.15625
▁medical 3.017578125
▁mar 0.022705078125
iju 0.007282257080078125
ana 5.1975250244140625e-05
, 0.1280517578125
▁and 0.06591796875
▁mixed 6.1796875
▁OP 8.859375
MM 5.75390625
▁groups 0.473876953125
▁number 7.8828125
ed 0.01100921630859375
▁ 0.12042236328125
5 2.2421875
7 2.49609375
. 0.21533203125
1 2.37109375
%, 0.23486328125
▁ 0.004833221435546875
2 3.00390625
2 2.43359375
. 0.1085205078125
3 2.232421875
%, 0.11566162109375
▁and 0.0341796875
▁ 0.003047943115234375
5 3.212890625
1 2.525390625
. 0.1722412109375
4 2.14453125
%, 0.393798828125
▁respectively 0.01079559326171875
. 0.29150390625
▁The 1.4619140625
▁pl 4.6015625
ur 0.022064208984375
ality 3.1113624572753906e-05
▁of 0.042236328125
▁anx 0.89306640625
iety 0.01128387451171875
▁contained 11.09375
▁ 0.564453125
4 1.6005859375
8 2.392578125
. 0.06365966796875
4 2.3046875
% 0.5009765625
▁among 1.537109375
▁OP 6.4609375
▁patients 9.0859375
, 0.268310546875
▁ 0.09844970703125
2 1.5126953125
1 2.421875
. 0.1317138671875
5 2.423828125
% 0.01171875
▁among 0.4453125
▁MM 0.318603515625
▁patients 0.253662109375
, 0.0139617919921875
▁and 0.01407623291015625
▁ 0.037445068359375
3 1.2470703125
8 2.640625
. 0.1583251953125
7 2.294921875
% 0.01352691650390625
▁among 0.2445068359375
▁OP 4.23046875
MM 0.2288818359375
▁participants 3.638671875
. 0.235107421875
▁Pat 5.8046875
ients 0.0224609375
▁who 2.37109375
▁took 2.927734375
▁strong 8.234375
▁op 1.2431640625
i 1.4111328125
ates 0.003520965576171875
▁were 1.759765625
▁t 8.9140625
ended 1.2177734375
▁to 0.0147552490234375
▁place 10.3125
▁their 3.67578125
▁pain 2.623046875
▁on 3.427734375
▁a 0.8974609375
▁scale 2.306640625
▁of 0.62548828125
▁ 0.3046875
9 2.876953125
▁to 1.3701171875
▁ 0.0156402587890625
1 0.023162841796875
0 0.0904541015625
▁( 2.572265625
Fe 1.6337890625
ing 0.00783538818359375
old 0.0004754066467285156
▁et 0.0300140380859375
▁al 0.0009336471557617188
., 0.0078887939453125
▁ 0.00196075439453125
2 0.0005612373352050781
0 5.1140785217285156e-05
1 0.001728057861328125
7 0.01255035400390625
). 0.05157470703125
▁They 4.69140625
▁were 1.2744140625
▁also 1.396484375
▁an 8.828125
gu 4.73046875
ished 0.035552978515625
▁em 8.484375
otion 0.01043701171875
ally 0.00420379638671875
▁and 1.1611328125
▁react 6.8828125
ed 0.05908203125
▁rad 9.5078125
ically 0.003063201904296875
▁neg 5.453125
atively 0.0010271072387695312
▁to 0.365966796875
▁almost 5.26171875
▁all 1.1845703125
▁survey 8.4140625
▁questions 0.6337890625
. 0.2978515625
▁Pat 4.23828125
ients 0.00814056396484375
▁who 1.1513671875
▁took 1.521484375
▁only 5.51171875
▁MM 0.8701171875
▁or 3.265625
▁mixed 3.423828125
▁medic 2.619140625
ations 0.33837890625
▁course 12.609375
▁had 2.474609375
▁a 1.28515625
▁significantly 2.560546875
▁more 4.03515625
▁stable 3.375
▁emot 1.1787109375
ional 0.00824737548828125
▁state 0.81494140625
▁and 1.4453125
▁cop 5.51953125
ed 0.8271484375
▁with 0.732421875
▁pain 1.4521484375
▁more 1.6845703125
▁manage 6.98828125
able 2.421875
. 0.5234375
<0x0A> 0.71923828125
One 5.1796875
▁of 0.59521484375
▁the 0.0183258056640625
▁major 2.5703125
▁limitations 2.763671875
▁is 3.830078125
▁the 0.5166015625
▁ins 4.73828125
u 0.0182647705078125
fficient 0.11993408203125
ly 4.65234375
▁high 2.97265625
▁response 2.97265625
▁rate 0.12384033203125
, 2.603515625
▁ 4.546875
5 1.9287109375
7 2.052734375
% 2.0234375
▁instead 7.4453125
▁of 0.007106781005859375
▁ 0.7236328125
7 1.537109375
0 1.453125
% 1.078125
▁( 1.66015625
Fe 0.2578125
ing 0.0036945343017578125
old 0.0005178451538085938
▁et 0.006587982177734375
▁al 0.0006580352783203125
., 0.00536346435546875
▁ 0.0015268325805664062
2 0.00042748451232910156
0 2.7894973754882812e-05
1 0.0008559226989746094
7 0.0061798095703125
). 0.03851318359375
▁It 2.681640625
▁can 3.271484375
▁be 0.427734375
▁fairly 8.3359375
▁explained 1.46484375
▁by 0.1744384765625
▁the 0.33056640625
▁weak 8.25
▁focus 7.11328125
▁of 0.463623046875
▁respond 6.2890625
ents 0.1356201171875
▁who 3.517578125
▁hav 12.8125
▁e 1.9501953125
▁overcome 8.3984375
▁severe 2.345703125
▁pain 0.61279296875
▁sens 8.9765625
ations 1.1015625
▁and 1.361328125
▁de 4.140625
press 1.7861328125
ive 0.262939453125
▁episodes 4.0234375
. 0.6103515625
▁It 3.33984375
▁is 0.87451171875
▁not 2.671875
▁clear 4.28125
▁how 1.7177734375
▁to 3.529296875
▁use 5.39453125
▁these 3.017578125
▁statistics 3.4296875
, 2.5859375
▁as 1.388671875
▁they 1.3759765625
▁still 6.12890625
▁may 4.7578125
▁be 1.314453125
▁relevant 5.31640625
▁for 1.369140625
▁the 1.845703125
▁overall 4.46484375
▁analysis 3.029296875
. 1.02734375
